X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2092) 2092
Publication (251) 251
Newsletter (90) 90
Book Review (13) 13
Newspaper Article (13) 13
Dissertation (10) 10
Book Chapter (7) 7
Magazine Article (5) 5
Report (2) 2
Reference (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1571) 1571
lamivudine (1268) 1268
hiv infections - drug therapy (842) 842
female (830) 830
male (825) 825
index medicus (780) 780
adult (739) 739
lamivudine - therapeutic use (664) 664
infectious diseases (646) 646
hiv (638) 638
anti-hiv agents - therapeutic use (534) 534
middle aged (477) 477
zidovudine (453) 453
virology (439) 439
pharmacology & pharmacy (419) 419
drug therapy, combination (415) 415
antiretroviral therapy (410) 410
mutation (370) 370
tenofovir (370) 370
hiv-1 - drug effects (360) 360
hiv infections - virology (346) 346
lamivudine - pharmacology (343) 343
human immunodeficiency virus--hiv (329) 329
antiviral agents (325) 325
viral load (323) 323
treatment outcome (321) 321
reverse transcriptase inhibitors - therapeutic use (319) 319
therapy (311) 311
lamivudine - administration & dosage (309) 309
drug therapy (308) 308
hiv infection (300) 300
immunology (293) 293
antiretroviral drugs (289) 289
cd4 lymphocyte count (263) 263
zidovudine - therapeutic use (258) 258
infection (244) 244
hiv-1 - genetics (240) 240
anti-hiv agents - administration & dosage (239) 239
highly active antiretroviral therapy (239) 239
anti-hiv agents - pharmacology (238) 238
aids (232) 232
microbiology (229) 229
emtricitabine (223) 223
drug resistance (221) 221
research (221) 221
adenine - analogs & derivatives (212) 212
health aspects (212) 212
hiv-1 (209) 209
reverse transcriptase inhibitors - pharmacology (208) 208
virus diseases (196) 196
analysis (195) 195
hepatitis b virus - drug effects (195) 195
antiviral agents - therapeutic use (194) 194
human-immunodeficiency-virus (193) 193
hepatitis b virus - genetics (192) 192
anti-hiv agents - adverse effects (190) 190
hepatitis b (188) 188
hepatitis b, chronic - drug therapy (188) 188
hepatitis b virus (182) 182
replication (181) 181
drug resistance, viral (179) 179
efavirenz (178) 178
lamivudine - adverse effects (176) 176
abacavir (175) 175
nevirapine (175) 175
human immunodeficiency virus (172) 172
animals (170) 170
resistance (165) 165
viruses (164) 164
stavudine (161) 161
antiretroviral agents (160) 160
care and treatment (156) 156
research article (156) 156
adolescent (154) 154
in-vitro (152) 152
protease inhibitors (152) 152
acquired immune deficiency syndrome--aids (150) 150
reverse-transcriptase (149) 149
drug combinations (148) 148
antiviral agents - pharmacology (147) 147
mutations (146) 146
zidovudine - administration & dosage (145) 145
antiretroviral therapy, highly active (144) 144
aged (141) 141
drug resistance, viral - genetics (141) 141
efficacy (140) 140
pharmacokinetics (140) 140
gastroenterology & hepatology (138) 138
pregnancy (138) 138
reverse transcriptase inhibitors - administration & dosage (138) 138
drugs (136) 136
medicine (133) 133
patients (133) 133
adenine - therapeutic use (131) 131
young adult (131) 131
dosage and administration (130) 130
zidovudine - pharmacology (127) 127
multidisciplinary sciences (124) 124
combination therapy (123) 123
drug-resistance (122) 122
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2163) 2163
Chinese (14) 14
French (13) 13
Spanish (11) 11
Japanese (7) 7
Korean (4) 4
Portuguese (4) 4
German (3) 3
Italian (1) 1
Polish (1) 1
Russian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Organic Letters, ISSN 1523-7060, 06/2015, Volume 17, Issue 11, pp. 2626 - 2629
The combined use of silanes (Et3SiH or PMHS) and I-2 as novel N-glycosidation reagents for the synthesis of bioactive oxathiolane nucleosides 3TC and FTC is... 
SYSTEM | I-2/ET3SIH | ACTIVATION | NUCLEOSIDE ANALOGS | DRUGS | PYRIMIDINE | CHEMISTRY, ORGANIC | SUGARS | ACCESS | Emtricitabine | Deoxycytidine - chemistry | Stereoisomerism | Lamivudine - chemistry | Glycosylation | Molecular Structure | Lamivudine - chemical synthesis | Deoxycytidine - analogs & derivatives | Deoxycytidine - chemical synthesis
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 08/2019, Volume 81, Issue 4, pp. 463 - 472
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/1999, Volume 96, Issue 18, pp. 10027 - 10032
Journal Article
Phosphorus, Sulfur, and Silicon and the Related Elements, ISSN 1042-6507, 09/2017, Volume 192, Issue 9, pp. 989 - 1001
Lamivudine (3TC; 2,3-dideoxy-3-thiacytidine) is a reverse transcriptase inhibitor and used for the treatment of human immunodeficiency virus-1 (HIV-1) and... 
drug discovery | hepatitis B | HIV infection | Lamivudine (3TC) | ASYMMETRIC-SYNTHESIS | POTENT ANTIVIRAL AGENT | CHRONIC HEPATITIS-B | STEREOCHEMISTRY | CHEMISTRY, ORGANIC | ANTI-HIV AGENTS | DYNAMIC KINETIC RESOLUTION | CHEMISTRY, INORGANIC & NUCLEAR | ENANTIOMERICALLY PURE | 3TC(TM) | BIOLOGICAL EVALUATION | HBV
Journal Article
Environmental and Molecular Mutagenesis, ISSN 0893-6692, 04/2007, Volume 48, Issue 3‐4, pp. 190 - 200
Journal Article
by Flandre, P and Pugliese, P and Allavena, C and Katlama, C and Cotte, L and Cheret, A and Cabié, A and Rey, D and Chirouze, C and Bani‐Sadr, F and Cuzin, L and Enel, P and Obry‐Roguet, V and Faucher, O and Bregigeon, S and Poizot‐Martin, I and Marchou, B and Massip, P and Bonnet, E and Obadia, M and Alvarez, M and Porte, L and Delobel, P and Chauveau, M and Garipuy, D and Mularczyk, M and Bernard, J and Lepain, I and Marcel, M and Puntis, E and Sauné, K and Pugliese, P and Ceppi, C and Cua, E and Cottalorda, J and Dellamonica, P and Demonchy, E and Dunais, B and Durant, J and Etienne, C and Ferrando, S and Fuzibet, J. G and Garraffo, R and Risso, K and Mondain, V and Naqvi, A and Oran, N and Perbost, I and Pillet, S and Prouvost‐Keller, B and Pradier, C and Wehrlen‐Pugliese, S and Rosenthal, E and Sausse, S and Roger, P.M and Bernaud, C and Billaud, E and Biron, C and Bonnet, B and Bouchez, S and Boutoille, D and Brunet‐Cartier, C and Hall, N and Jovelin, T and Morineau, P and Raffi, F and Reliquet, V and Hue, H and Larmet, L and Pineau, So and Ferré, V and André‐Garnier, E and Rodallec, A and Choisy, P and Yazdanpanah, Y and Landman, R and Duvivier, C and Valantin, M.A and Agher, R and Lortholary, . and Avettand‐Fenoel, V and Rouzioux, C and Consigny, P.H and Cessot, G and Touam, F and Usubillaga, R and Benhadj, K and Abel, S and Pierre‐François, S and Ouka, M and Martial, J and Ebel, E and Fischer, P and Partisani, M and Cheneau, C and Priester, M and Batard, ML and Bernard‐Henry, C and Mautort, E and Drobacheff‐Thiébaut, C and ... and Dat'AIDS Study Grp and Dat'AIDS Study group and the Dat'AIDS Study group
HIV Medicine, ISSN 1464-2662, 05/2016, Volume 17, Issue 5, pp. 380 - 384
Journal Article
European Journal of Pharmaceutical Sciences, ISSN 0928-0987, 12/2012, Volume 47, Issue 5, pp. 965 - 978
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2014, Volume 9, Issue 2, p. e88305
Journal Article
Journal Article
Journal Article